US Stocks
/
Neurogene Inc. Share Price
Neurogene Inc. Share Price

Neurogene Inc. Share Price

NASDAQ: NGNE | Small Cap
$32.05
-$0.50 (-1.54%) Last updated on 19 Sep, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Neurogene Inc. Stock Performance

Open
$33.15
Prev. Close
$32.55
Circuit Range
N/A
Day Range
$31.96 - $33.15
Year Range
$16.00 - $43.39
Volume
11,047
Average Traded
$32.39

Neurogene Inc. Share Price Today

As of 19 September 2026, Neurogene Inc.'s share price is $32.05. The stock opened at $33.15, compared to its previous close of $32.55. During today's trading session, Neurogene Inc.'s share price traded between $31.96 and $33.15, with an average price of $32.55. Over the past 52 weeks, the stock has recorded a high of $43.39 and a low of $16.00. In terms of performance, Neurogene Inc.'s share price has risen by 58.51% over the last six months and is up 84.30% on a year-on-year basis.

Neurogene Inc. Share Price Chart

$31.96$33.15
L
Show Current Price
H

Neurogene Inc. Stock Fundamentals & Key Indicators

Market Cap
$683.51M
PE Ratio (TTM)
-7.56
Dividend Yield
N/A
EPS (TTM)
$-4.24
Revenue (TTM)
N/A
Return On Equity (TTM)
-34.11%
Profit Margin
N/A
Debt to Equity
0.06
Quarterly Earnings Growth YoY
-13.31%

Neurogene Inc. Quarterly Profit & Loss

All figures in USD

ParticularsJun 2024Sep 2024Jun 2025Sep 2025
Revenue$925000.00$0.00$0.00$0.00
Net Profit-$18.49M-$20.22M-$22.02M-$20.95M
Net Profit Margin-1999.14%N/AN/AN/A
Income ChangeN/A-9.33%-8.90%4.83%

Neurogene Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$925000.00$0.00
Net Profit-$75.14M-$90.35M
Net Profit Margin-8123.68%N/A
Income ChangeN/A-20.24%

About Neurogene Inc.

Neurogene Inc., a clinical stage biotechnology company, develops genetic medicines for rare neurological diseases. The company's product candidates include NGN-401 that is packaged in an adeno-associated virus 9, which is in Phase 1/2 clinical trial for the treatment of Rett syndrome; and NGN-101, a conventional gene therapy candidate that is in Phase 1/2 clinical trial to treat CLN5 Batten disease. It has a license agreements with The University of Edinburgh, Virovek, Inc., Sigma-Aldrich Co. LLC., and Leland Stanford Junior University. The company was founded in 2018 and is headquartered in New York, New York.

Neurogene Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$36.01
$32.01
-15.00%
Aug 2026
$33.60
$37.66
+14.84%
Jul 2026
$32.46
$32.79
+4.68%
Jun 2026
$28.57
$31.32
+11.10%
May 2026
$24.88
$28.20
+8.11%
Apr 2026
$21.28
$26.08
+28.98%
Mar 2026
$23.02
$20.22
-13.88%
Feb 2026
$18.11
$23.48
+33.48%
Jan 2026
$20.42
$17.59
-15.29%
Dec 2025
$20.13
$20.77
-1.68%
Nov 2025
$30.52
$21.12
-38.34%
Oct 2025
$18.13
$34.26
+96.98%

NGNE Share Price FAQs

What is Neurogene Inc. share price today?

chevron-up
Neurogene Inc. share price today is $32.05 as on September 19, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Neurogene Inc. stock?

chevron-up
The 52 week high of Neurogene Inc. stock is $43.39, while the 52 week low is $16.00 as of 19 Sep '26.

What is NGNE's market capitalisation today?

chevron-up
NGNE market capitalisation is $683.51M as of September 19, 2026, at 1:49 am IST.

What is NGNE's net income for the last quarter?

chevron-up
NGNE's net income for the last quarter is -0.02B USD.

What is the 5 year returns of NGNE?

chevron-up
The 5 year returns of NGNE is -77.84% as on 19 Sep '26.

What is the high & low stock price of NGNE today?

chevron-up
NGNE stock price hit a high of $33.15 and low of $31.96 as of 19 Sep '26.

Can I buy NGNE shares in India?

chevron-up
Yes. You can buy NGNE in India by opening an international trading account.